ArticleThe Indian journal of medical research2018

S961, a biosynthetic insulin receptor antagonist, downregulates insulin receptor expression & suppresses the growth of breast cancer cells.

Prateek Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.